X0306 4 2022-08-08 0 0001805387 Cerevel Therapeutics Holdings, Inc. CERE 0001816720 Akamine Scott C/O CEREVEL THERAPEUTICS HOLDINGS, INC. 222 JACOBS STREET, SUITE 200 CAMBRIDGE MA 02141 0 1 0 0 Chief Legal Officer Common Stock 2022-08-08 4 M 0 10000 13.17 A 10000 D Common Stock 2022-08-08 4 S 0 10000 40.0001 D 0 D Stock Option (Right to Buy) 13.17 2022-08-08 4 M 0 10000 0.00 D 2031-06-01 Common Stock 10000 271762 D These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 16, 2022 adopted by the Reporting Person. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 - $40.07. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. 25% of the shares subject to this option vested and became exercisable on June 1, 2022, with the remainder vesting in thirty-six (36) equal monthly installments thereafter. Exhibit 24 - Power of Attorney /s/ Mark Bodenrader, as Attorney-in-Fact 2022-08-09